Categories

Available data shows that vaccines' benefits far outweigh their known risks ❤️. Vaccines bring us closer together 🧔🏿👩🏽‍🦱👵🏾👴🏾👩🏾👴🏽 Get vaxxed

Available data shows that vaccines' benefits far outweigh their known risks ❤️.

Vaccines bring us closer together 🧔🏿👩🏽‍🦱👵🏾👴🏾👩🏾👴🏽

Get vaxxed this holiday season and keep your loved ones safe.

#HealthyHolidays https://t.co/PFBzSzFY3c

 
Categories

Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-Up

Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # R2200232 Exp: 01/2025 to the consumer/user level.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/accord-healthcare-inc-issues-nationwide-voluntary-recall-daptomycin-injection-500-mgvial-and

 
Categories

Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, Due To The Presence of Visible Glass Particulates

Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride Injection, USP, 1.5 g/vial Single Dose Flip-top Vial, lot 33045BA, to the user level due to two visible glass particulates observed in a single vial.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-one-lot-vancomycin-hydrochloride-injection-usp